Pluristem Therapeutics Will Chair a Panel Presentation on Placenta-Derived Adult Stem Cells at the World Conference on Regenerative Medicine
HAIFA, Israel, Oct 20, 2009 (BUSINESS WIRE) -- Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it will chair a panel entitled: "Placenta-Derived Adult Stem Cells as an Allogeneic Alternative to Mesenchymal Stromal Cells (MSCs)" at the World Conference on Regenerative Medicine at the Congress Center Leipzig, in Leipzig, Germany. Edwin M. Horwitz, M.D., Ph.D., chairman of Pluristem's scientific advisory board, will present, as the keynote speaker, the clinical landscape of MSCs and Pluristem's clinical trial for the treatment of critical limb ischemia (CLI), an example of non-HLA matched allogeneic local delivery of placenta-derived MSCs, at 10:45 a.m. CET, Oct. 30, 2009.
"Placenta-derived stem cells may offer a viable allogeneic alternative to MSCs from bone marrow, cord blood and other sources," said Dr. Horwitz. "Clinical trials with Pluristem's placental expanded cells may eventually demonstrate that placenta-derived stromal cells are a viable treatment for a variety of degenerative, ischemic and autoimmune disorders, including CLI."
Participants on the panel will include Hans-Dieter Volk, Ph.D., professor of immunology and chair of the Institute of Medical Immunology Charite - Universitatsmedizin Berlin and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), who will present on the immunological behavior of MSCs. Frida Grynspan, Ph.D., Pluristem's vice president of research & development, will present on the placenta as an alternative and preferential source of MSCs.
The World Conference on Regenerative Medicine 2009 will be held on Oct. 29-31, 2009, in Leipzig, Germany. The Fraunhofer Institute for Cell Therapy and Immunology is the organizer and host of this event and the Translational Center for Regenerative Medicine (TRM) Leipzig is the co-organizer. Over 1,000 participants from research institutes, clinics and industry are expected to participate in the conference. Topics include: stem cells, tissue engineering, technology development, immunology & signaling and regulatory affairs. For more information on this event, please visit: www.wcrm-leipzig.com. |
